Acute Myopericarditis in the Post COVID-19 Recovery Phase
SARS-CoV-2, covid-19, acute myopericarditis
Cardiology | Cardiovascular Diseases | Emergency Medicine | Infectious Disease | Virus Diseases
The COVID-19 viral infection, caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a currently ongoing global pandemic that, as of mid-October, 2020, has resulted in more than 38.7 million confirmed cases globally and has caused more than 1.1 million fatalities. COVID-19 infection is associated with severe life threatening respiratory and cardiac complications such as acute respiratory distress syndrome (ARDS), pneumonia, shock, cardiac arrhythmias, myocardial infarction and heart failure, particularly in the acute infectious stage. Acute myopericarditis is another reported cardiac complication of COVID-19. Case reports have been limited in reporting the effects of COVID-19 in the post-symptomatic period.
In this article, we present a case of acute myopericarditis resulting 6 to 8 weeks after testing positive for COVID-19. Here we will breakdown the initial emergency department (ED) presentation, with particular attention to the electrocardiogram (ECG) findings of acute myopericarditis. This case, to the our best knowledge and after an extensive literature review, depicts the first case of myopericarditis in the post COVID-19 infection recovery phase.
Publisher or Conference
Rivera-Morales M D, Pell R, Rubero J, et al. Acute Myopericarditis in the Post COVID-19 Recovery Phase. Cureus. 2020;12(10):e11247. https://doi.org/10.7759/cureus.11247